Resources

Type of publications
Regions
Diseases

5192 results found

2020 ∙ Abidi, S. Labani, S. Singh, A. Asthana, S. Ajmera, P.

Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Murfin, J. Irvine, F. Meechan-Rogers, R. Swift, A.

Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review

  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Carazo, S. Billard, M. N. Boutin, A. De Serres, G.

Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis

  • Newborn
  • Children
  • Measles
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Mo, Y. Zeng, J. Xiao, C. Zhang, L. Wang, L. Lu, F. Johnson, D. W. Stålsby Lundborg, C. Nitsch, D. Liu, X. Su, G.

Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2020 ∙ Ortiz, E. Scanlon, B. Mullens, A. Durham, J.

Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries

  • All age groups
  • Hepatitis B
  • Hepatitis C
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Yang, J. Zhang, J. Han, T. Liu, C. Li, X. Yan, L. Yang, B. Yang, X.

Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Whitworth, H. S. Gallagher, K. E. Howard, N. Mounier-Jack, S. Mbwanji, G. Kreimer, A. R. Basu, P. Kelly, H. Drolet, M. Brisson, M. Watson-Jones, D.

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Quan, T. M. Thao, T. T. N. Duy, N. M. Nhat, T. M. Clapham, H.

Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015

  • All age groups
  • Japanese encephalitis
  • Administration
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Onwuchekwa, C. Edem, B. Williams, V. Oga, E.

Estimating the impact of pneumococcal conjugate vaccines on childhood pneumonia in sub-Saharan Africa: A systematic review

  • Africa
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Godfrey, O. Zhang, W. Amponsem-Boateng, C. Bonney Oppong, T. Zhao, Q. Li, D.

Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis

  • Africa
  • Newborn
  • Children
  • Rotavirus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...